Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression.

Lawton, M., Ben-Shlomo, Y., Gkatzionis, A., Hu, M. T., Grosset, D. and Tilling, K. (2024) Two sample Mendelian Randomisation using an outcome from a multilevel model of disease progression. European Journal of Epidemiology, (doi: 10.1007/s10654-023-01093-2) (PMID:38281297) (Early Online Publication)

[img] Text
319505.pdf - Published Version
Available under License Creative Commons Attribution.

962kB

Abstract

Identifying factors that are causes of disease progression, especially in neurodegenerative diseases, is of considerable interest. Disease progression can be described as a trajectory of outcome over time—for example, a linear trajectory having both an intercept (severity at time zero) and a slope (rate of change). A technique for identifying causal relationships between one exposure and one outcome in observational data whilst avoiding bias due to confounding is two sample Mendelian Randomisation (2SMR). We consider a multivariate approach to 2SMR using a multilevel model for disease progression to estimate the causal effect an exposure has on the intercept and slope. We carry out a simulation study comparing a naïve univariate 2SMR approach to a multivariate 2SMR approach with one exposure that effects both the intercept and slope of an outcome that changes linearly with time since diagnosis. The simulation study results, across six different scenarios, for both approaches were similar with no evidence against a non-zero bias and appropriate coverage of the 95% confidence intervals (for intercept 93.4–96.2% and the slope 94.5–96.0%). The multivariate approach gives a better joint coverage of both the intercept and slope effects. We also apply our method to two Parkinson’s cohorts to examine the effect body mass index has on disease progression. There was no strong evidence that BMI affects disease progression, however the confidence intervals for both intercept and slope were wide.

Item Type:Articles
Additional Information:Funding Both the Oxford Discovery (grant reference J-1403) and Tracking Parkinson’s (PRoBaND) cohorts (grant reference J-1101) were funded by Parkinson’s UK. KT and AG work in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol which is supported by the Medical Research Council and the University of Bristol (MC_UU_00011/3).
Keywords:Multivariate meta-analysis, Parkinson’s disease, Two sample Mendelian Randomisation
Status:Early Online Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Grosset, Professor Donald
Authors: Lawton, M., Ben-Shlomo, Y., Gkatzionis, A., Hu, M. T., Grosset, D., and Tilling, K.
College/School:College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience
Journal Name:European Journal of Epidemiology
Publisher:Springer
ISSN:0393-2990
ISSN (Online):1573-7284
Copyright Holders:Copyright: © The Author(s) 2024
First Published:First published in European Journal of Epidemiology 2024
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
173486Tracking Parkinson's: The long term development and analysis of the Parkinson's repository of biomarkers and networked datasets (PROBAND phase 2)Donald GrossetParkinson's Disease Society of the UK (T/a Parkinson's UK) (PARKINSO)J-1101 extensionSPN - Centre for Stroke & Brain Imaging